Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030

Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030


The Insomnia Drugs Market size was estimated at USD 2.92 billion in 2023 and expected to reach USD 3.07 billion in 2024, at a CAGR 5.67% to reach USD 4.30 billion by 2030.

Global Insomnia Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Insomnia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Insomnia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Astellas Pharma Inc., Aurobindo Pharma Limited, Biogen SA, Cadila Healthcare Ltd., Dr.Reddy’s Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, Flynn Pharma Limited, Glenmark Pharmaceuticals Ltd., Idorsia Pharmaceuticals Ltd., LA Herbal (India), Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Minerva Neurosciences, Inc., Neuracle Lifesciences Private Limited, Neurim Pharmaceuticals LTD., Orexo AB, Pfizer Inc., Purdue Pharma L.P., Sanofi Group, Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Vanda Pharmaceuticals Inc., and Wockhardt Limited.

Market Segmentation & Coverage

This research report categorizes the Insomnia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Anti-Parkinsonian Drugs

Anticonvulsants

Antidepressants

Antinarcoleptics

Benzodiazepines

Nonbenzodiazepines

Orexin Antagonist

Ramelteon

Distribution Channels
Online Pharmacies

Retail Pharmacies

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Insomnia Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Insomnia Drugs Market?
3. What are the technology trends and regulatory frameworks in the Insomnia Drugs Market?
4. What is the market share of the leading vendors in the Insomnia Drugs Market?
5. Which modes and strategic moves are suitable for entering the Insomnia Drugs Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Insomnia Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of insomnia across the world
5.1.1.2. Rising awareness about various treatment options available for insomnia
5.1.2. Restraints
5.1.2.1. Side effects associated with insomnia drugs
5.1.3. Opportunities
5.1.3.1. Continuous research and development to develop novel insomnia drugs
5.1.3.2. Increase in number of insomnia centers and sleep diagnostic centers
5.1.4. Challenges
5.1.4.1. Misconceptions about the seriousness of insomnia and patients' non-adherence to the treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Insomnia Drugs Market, by Type
6.1. Introduction
6.2. Anti-Parkinsonian Drugs
6.3. Anticonvulsants
6.4. Antidepressants
6.5. Antinarcoleptics
6.6. Benzodiazepines
6.7. Nonbenzodiazepines
6.8. Orexin Antagonist
6.9. Ramelteon
7. Insomnia Drugs Market, by Distribution Channels
7.1. Introduction
7.2. Online Pharmacies
7.3. Retail Pharmacies
8. Americas Insomnia Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Insomnia Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.
10. South Korea
9.
11. Taiwan
9.
12. Thailand
9.
13. Vietnam
10. Europe, Middle East & Africa Insomnia Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.
10. Nigeria
10.
11. Norway
10.
12. Poland
10.
13. Qatar
10.
14. Russia
10.
15. Saudi Arabia
10.
16. South Africa
10.
17. Spain
10.
18. Sweden
10.
19. Switzerland
10.
20. Turkey
10.
21. United Arab Emirates
10.
22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Alembic Pharmaceuticals Limited
12.1.2. Astellas Pharma Inc.
12.1.3. Aurobindo Pharma Limited
12.1.4. Biogen SA
12.1.5. Cadila Healthcare Ltd.
12.1.6. Dr.Reddy’s Laboratories Limited
12.1.7. Eisai Co., Ltd.
12.1.8. Eli Lilly and Company
12.1.9. Flynn Pharma Limited
12.1.
10. Glenmark Pharmaceuticals Ltd.
12.1.
11. Idorsia Pharmaceuticals Ltd.
12.1.
12. LA Herbal (India)
12.1.
13. Mallinckrodt Pharmaceuticals
12.1.
14. Merck & Co., Inc.
12.1.
15. Minerva Neurosciences, Inc.
12.1.
16. Neuracle Lifesciences Private Limited
12.1.
17. Neurim Pharmaceuticals LTD.
12.1.
18. Orexo AB
12.1.
19. Pfizer Inc.
12.1.
20. Purdue Pharma L.P.
12.1.
21. Sanofi Group
12.1.
22. Sun Pharmaceutical Industries Limited
12.1.
23. Takeda Pharmaceutical Company Limited
12.1.
24. Vanda Pharmaceuticals Inc.
12.1.
25. Wockhardt Limited
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. INSOMNIA DRUGS MARKET RESEARCH PROCESS
FIGURE 2. INSOMNIA DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INSOMNIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INSOMNIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INSOMNIA DRUGS MARKET DYNAMICS
FIGURE 7. INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
FIGURE 10. INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings